Differential effect of plasma or erythrocyte AGE-ligands of RAGE on expression of transcripts for receptor isoforms

Diabetes and Metabolism

Volumn 35, Issue 5, 2009, Pages 410-417

  Grossin, N ^a   Wautier, M P S ^b   Picot, J ^c   Stern, D M ^d   Wautier, J L T ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b hôpital Robert Debré et Institut national de la transfusion sanguine   (France)

^c INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Adhesion; Advanced glycation endproducts; AGE; Diabetes; RAGE; Red blood cell

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; HUMAN SERUM ALBUMIN; MESSENGER RNA; METHYLGLYOXAL;

ARTICLE; CELL ADHESION; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIUM CELL; ERYTHROCYTE; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PLASMA; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UMBILICAL VEIN;

ANION EXCHANGE PROTEIN 1, ERYTHROCYTE; BASE SEQUENCE; BINDING, COMPETITIVE; CELL ADHESION; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; ENDOTHELIUM, VASCULAR; ERYTHROCYTES; GENE EXPRESSION REGULATION; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIGANDS; MOLECULAR SEQUENCE DATA; PROTEIN ISOFORMS; RECEPTORS, IMMUNOLOGIC; RNA, MESSENGER; SEQUENCE ALIGNMENT; SERUM ALBUMIN;

EID: 70449528677     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2009.04.009     Document Type: Article

References (22)

1. Wautier J.L., and Schmidt A.M. Protein glycation: a firm link to endothelial cell dysfunction. Circ Res 95 (2004) 233-238
2. Yonekura H., Yamamoto Y., Sakurai S., Petrova R.G., Abedin M.J., Li H., et al. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem J 370 (2003) 1097-1109
3. Galichet A., and Weibel M.H.CW. Calcium-regulated intramembrane proteolysis of the RAGE receptor. Biochem Biophys Res Commun 370 (2008) 1-5
4. Westwood M.E., and Thornalley P.J. Molecular characteristics of methylglyoxal-modified bovine and human serum albumins. Comparison with glucose-derived advanced glycation endproduct-modified serum albumins. J Protein Chem 14 (1995) 359-372
5. Shipanova I.N., Glomb M.A., and Nagaraj R.H. Protein modification by methylglyoxal: chemical nature and synthetic mechanism of a major fluorescent adduct. Arch Biochem Biophys 344 (1997) 29-36
6. Wautier M.P., Boulanger E., Guillausseau P.J., Massin P., and Wautier J.L. AGEs, macrophage colony stimulating factor and vascular adhesion molecule blood levels are increased in patients with diabetic microangiopathy. Thromb Haemost 91 (2004) 879-885
7. Wautier M.P., Massin P., Guillausseau P.J., Huijberts M., Levy B., Boulanger E., et al. N(carboxymethyl)lysine as a biomarker for microvascular complications in type 2 diabetic patients. Diabetes Metab 29 (2003) 44-52
8. Han Y., Randell E., Vasdev S., Gill V., Curran M., Newhook L.A., et al. Plasma advanced glycation endproduct, methylglyoxal-derived hydroimidazolone is elevated in young, complication-free patients with Type 1 diabetes. Clin Biochem 42 7-8 (2009) 562-569
9. Wautier J.L., Paton R.C., Wautier M.P., Pintigny D., Abadie E., Passa P., et al. Increased adhesion of erythrocytes to endothelial cells in diabetes mellitus and its relation to vascular complications. N Engl J Med 305 (1981) 237-242
10. Wautier M.P., Chappey O., Corda S., Stern D.M., Schmidt A.M., and Wautier J.L. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 280 (2001) E685-E694
11. Wellmann S., Taube T., Paal K., Graf V., Einsiedel H., Geilen W., et al. Specific Reverse Transcription-PCR Quantification of Vascular Endothelial Growth Factor (VEGF) Splice Variants by LightCycler Technology. Clin Chem 47 (2001) 654-660
12. Ikeda K., Higashi T., Sano H., Jinnouchi Y., Yoshida M., Araki T., et al. N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry 35 (1996) 8075-8083
13. Habeeb A.F. Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. Anal Biochem 14 (1966) 328-336
14. Boulanger E., Wautier M.P., Wautier J.L., Boval B., Panis Y., Wernert N., et al. AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression. Kidney Int 61 (2002) 148-156
15. Wautier J.L., Wautier M.P., Schmidt A.M., Anderson G.M., Hori O., Zoukourian C., et al. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications. Proc Natl Acad Sci U S A 91 (1994) 7742-7746
16. Wautier M.P., Khodabandehlou T., Le Devehat C., and Wautier J.L. Modulation of RAGE expression influences the adhesion of red blood cells from diabetic patients. Clin Hemorheol Microcirc 35 (2006) 379-386
17. Tanaka N., Yonekura H., Yamagishi S., Fujimori H., Yamamoto Y., and Yamamoto H. The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells. J Biol Chem 275 (2000) 25781-25790
18. Li J., and Schmidt A.M. Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products. J Biol Chem 272 (1997) 16498-16506
19. Hudson B.I., Carter A.M., Harja E., Kalea A.Z., Arriero M., Yang H., et al. Identification, classification, and expression of RAGE gene splice variants. FASEB J 22 (2007) 1572-1580
20. Miller J.A., Gravallese E., and Bunn H.F. Non enzymatic glycosylation of erythrocyte membrane proteins. Relevance to diabetes. J Clin Invest 65 (1980) 896-901
21. Koyama H., Shoji T., Fukumoto S., Shinohara K., Shoji T., Emoto M., et al. Low circulating endogenous secretory receptor for AGEs predicts cardiovascular mortality in patients with end-stage renal disease. Arterioscler Thromb Vasc Biol 27 (2005) 147-153
22. Grossin N., Wautier M.P., Meas T., Guillausseau P.J., Massin P., and Wautier J.L. Severity of diabetic microvascular complications is associated to low soluble RAGE level. Diabetes Metab 34 (2008) 392-395